Ian Anderson (@ianandersoncbre) 's Twitter Profile
Ian Anderson

@ianandersoncbre

CRE Economist; Office and Life Sciences Lab/R&D Specialist; Washington, DC Thought Leader.

ID: 1666044043

linkhttp://www.cbre.us/people-and-offices/ian-anderson calendar_today12-08-2013 20:58:39

545 Tweet

284 Followers

264 Following

CBRE (@cbre) 's Twitter Profile Photo

With all-time highs in funding, job growth, demand, and construction, the outlook for #lifesciences looks bright. Here are 5 things to know right now about the sector. Read more in CBRE's U.S. Life Sciences Trends report: cbre.co/3pDueea

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

Another sluggish start to the year, but spring should clear the way for more activity and a more discernable "return of the city." commercialobserver.com/2021/12/dc-com…

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

Quadrupled its footprint: Biotech Giant Horizon Therapeutics Expanding in Montgomery County commercialobserver.com/2022/01/biotec…

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

Real estate "Alternatives" are becoming less "alternatives" and more mainstream everyday....AREP, Harrison Street Plan $1B Data Center Project In Northern Virginia bisnow.com/national/news/…

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

See the my interview with two of CBRE's life sciences experts. What's driving the boom in life sciences? What are companies seeking for their lab/R&D facilities today? And where? What will 2022 look like? cbre.com/insights/books…

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

Next Thursday 2/17 at 11:00 a.m., I will be moderating a 2022 Outlook discussion entitled “What’s Next for Washington D.C.?” Register here to attend: events.bizzabo.com/385139 Looking forward to an exciting discussion! #dcrealestate #commercialrealestate #futureofwork

Next Thursday 2/17 at 11:00 a.m., I will be moderating a 2022 Outlook discussion entitled “What’s Next for Washington D.C.?” 
Register here to attend: events.bizzabo.com/385139 
Looking forward to an exciting discussion! #dcrealestate #commercialrealestate #futureofwork
Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

The rapid growth of life-sciences research during the pandemic is triggering a record development boom for new labs and offices serving these companies wsj.com/articles/deman… via The Wall Street Journal

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

Boeing plans to move headquarters to Washington, D.C., area from Chicago so executives can be closer to decision makers in the federal government wsj.com/articles/boein… via The Wall Street Journal

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

Washington-Baltimore's life sciences industry has grown 13.3% through the pandemic, exceeding U.S. growth. #DC #Baltimore #lifesciences

Washington-Baltimore's life sciences industry has grown 13.3% through the pandemic, exceeding U.S. growth. #DC #Baltimore #lifesciences
Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

The New New Haven: Artists, creatives, and...life sciences researchers - as shown in our 2022 Life Sciences Research Talent Report (lnkd.in/eVv6JUuH) - suggest New Haven is a burgeoning mid-sized cluster of activity. nytimes.com/2022/07/09/t-m…

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

Check out my latest article: Greater Washington Apartments Poised for Relative Growth and Resilience linkedin.com/pulse/greater-… via LinkedIn

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

The biotech sector had tumbled in the market selloff, but it is getting a boost from big investors and big pharmaceutical companies wsj.com/articles/biote… via The Wall Street Journal

CBRE Americas (@cbreamericas) 's Twitter Profile Photo

CBRE’s Taylor Stucky writes for Pharmaceutical Executive magazine about the influence cost-of-living differences can have on #LifeSciences recruitment & retention: cbre.co/3Btixwq #Biotech

Ian Anderson (@ianandersoncbre) 's Twitter Profile Photo

My colleague,Taylor Stucky, on how cost of living differences support - and don't support - growth in life sciences clusters around the U.S.